window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech & Pharma Business

  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development

    Icosagen completes €45M biologics manufacturing expansion

    Estonian biotechnology company Icosagen has completed a €45 million expansion [...]

    July 2, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Elixirgen signs worldwide option deal with Nippon Shinyaku for Duchenne therapy

    Elixirgen Therapeutics has signed an option agreement with Nippon Shinyaku [...]

    June 29, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    BioInnovation Institute expands into UK with London cardiometabolic innovation hub

    BioInnovation Institute has opened its first international base in London [...]

    June 29, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    China IgA nephropathy approval highlights rising dual-target biologic competition

    China’s approval of a first dual BAFF/APRIL therapy in IgA [...]

    June 25, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Racura treats first patient in Harness-1 lung cancer trial

    Racura Oncology has treated the first patient in its Harness-1 [...]

    June 25, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Research & Development,Therapeutic Areas

    EMBARC announces intention to collaborate with Insmed on landmark interventional study in bronchiectasis

    EMBARC has announced its intention to collaborate with Insmed on [...]

    June 28, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Research & Development

    Evogene advances ChemPass AI milestone in Google Cloud collaboration for autonomous small molecule discovery

    Evogene reports a major Google Cloud collaboration milestone advancing agentic [...]

    June 25, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Thalia Therapeutics acquires Sanmirna and raises £2.75M to advance AML RNA therapy

    Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

    June 25, 2026
  • Biotech & Pharma Business,Digital & Data

    Veeva acquires Copli and launches AI-powered content review platform

    Veeva Systems has acquired Copli and launched a new AI-powered [...]

    June 25, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Orphan Therapeutics Accelerator expands rare disease development network to advance ultra-rare therapies

    Orphan Therapeutics Accelerator has expanded its development network for ultra-rare [...]

    June 24, 2026
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA approves Meitheal’s rapid-acting insulin biosimilar Garzulys
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Verdiva Bio starts Phase 1 trial of once-weekly oral amylin drug for obesity
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Clean Cells acquires Anaquant to expand mass spectrometry capabilities in biopharma quality control
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top